Home » Stocks » Twist Bioscience

Twist Bioscience Corporation (TWST)

Stock Price: $54.71 USD -1.52 (-2.70%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 2.43B
Revenue (ttm) 65.80M
Net Income (ttm) -146.50M
Shares Out 44.46M
EPS (ttm) -4.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 10, 2020
Last Price $54.71
Previous Close $56.23
Change ($) -1.52
Change (%) -2.70%
Day's Open 56.00
Day's Range 54.36 - 57.13
Day's Volume 375,208
52-Week Range 18.52 - 57.33

More Stats

Market Cap 2.43B
Enterprise Value 2.24B
Earnings Date (est) Jul 30, 2020
Ex-Dividend Date n/a
Shares Outstanding 44.46M
Float 32.97M
EPS (basic) -4.41
EPS (diluted) -4.41
FCF / Share -4.11
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 4.82M
Short Ratio 6.91
Short % of Float 11.33%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 36.97
PB Ratio 9.19
Revenue 65.80M
Operating Income -147.61M
Net Income -146.50M
Free Cash Flow -152.86M
Net Cash 189.59M
Net Cash / Share 4.26
Gross Margin 10.58%
Operating Margin -224.33%
Profit Margin -222.70%
FCF Margin -232.33%
ROA -33.70%
ROE -77.17%
ROIC -108.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 2
Overweight 1
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$43.00*
(-21.40% downside)
Low
35.0
Current: 54.71
High
55.0
Target: 43.00
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016
Revenue54.3925.4310.772.27
Revenue Growth113.89%136.16%374.53%-
Gross Profit6.96-6.76-13.25-7.15
Operating Income-109-70.56-58.48-43.66
Net Income-108-71.24-59.31-44.09
Shares Outstanding27.462.792.421.87
Earnings Per Share-3.92-25.51-24.49-23.58
Operating Cash Flow-87.94-66.16-51.30-38.59
Capital Expenditures-14.74-3.67-6.33-6.23
Free Cash Flow-103-69.84-57.63-44.82
Cash & Equivalents13880.7662.2055.92
Total Debt7.739.729.1511.18
Net Cash / Debt13071.0453.0544.74
Assets18711685.6676.46
Liabilities34.9126.7319.3819.04
Book Value152-201-133-76.61
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Twist Bioscience Corporation
Country United States
Employees 414
CEO Emily Marine Leproust

Stock Information

Ticker Symbol TWST
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: TWST
IPO Date October 31, 2018

Description

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. Twist Bioscience Corporation has collaboration agreements with Pandion Therapeutics, Inc. and Schrödinger Inc. It also has a partnership with Serimmune Inc. to identify and evaluate SARS-CoV-2 therapeutic antibody candidates. The company was founded in 2013 and is headquartered in South San Francisco, California.